Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
09 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250608582351/en/Samsung-Bioepis-Enters-into-a-Strategic-Partnership-with-NIPRO-for-Commercialization-of-Multiple-Biosimilars-in-Japan
06 Jun 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761350
27 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250527970852/en/US-Food-and-Drug-Administration-FDA-Grants-Interchangeability-Designation-to-Samsung-Bioepis-and-Organon-HADLIMA-adalimumab-bwwd-Injection
21 May 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761059
24 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250424070511/en/Samsung-Bioepis-Second-Quarter-2025-Biosimilar-Market-Report-Highlights-US-Debut-of-Ustekinumab-Biosimilars-with-WAC-discounts-over-80-and-Regulatory-Streamlining
07 Apr 2025
// PRESS RELEASE
https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2025/Teva-and-Samsung-Bioepis-Announce-Biosimilar-EPYSQLI-eculizumab-aagh-InjectionNow-Available-in-the-United-States/default.aspx
ABOUT THIS PAGE